Your browser doesn't support javascript.
loading
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.
Choueiri, T K; Motzer, R J; Rini, B I; Haanen, J; Campbell, M T; Venugopal, B; Kollmannsberger, C; Gravis-Mescam, G; Uemura, M; Lee, J L; Grimm, M-O; Gurney, H; Schmidinger, M; Larkin, J; Atkins, M B; Pal, S K; Wang, J; Mariani, M; Krishnaswami, S; Cislo, P; Chudnovsky, A; Fowst, C; Huang, B; di Pietro, A; Albiges, L.
Afiliación
  • Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, USA. Electronic address: toni_choueiri@dcfi.harvard.edu.
  • Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Rini BI; Cleveland Clinic, Cleveland, USA.
  • Haanen J; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Campbell MT; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Venugopal B; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Kollmannsberger C; British Columbia Cancer Agency, Vancouver Centre, Vancouver, Canada.
  • Gravis-Mescam G; Institut Paoli-Calmettes, Department of Medical Oncology, Aix-Marseille Université, Inserm, CNRS, CRCM, Marseille, France.
  • Uemura M; Osaka University Hospital, Osaka, Japan.
  • Lee JL; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Grimm MO; Jena University Hospital, Department of Urology, Jena, Germany.
  • Gurney H; Macquarie University, Sydney, Australia.
  • Schmidinger M; Clinical Division of Oncology, Department of Medicine I Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Larkin J; Royal Marsden NHS Foundation Trust, London, UK.
  • Atkins MB; Georgetown University Medical Center, Washington, DC.
  • Pal SK; City of Hope National Medical Center, Duarte, USA.
  • Wang J; Pfizer, Cambridge, USA.
  • Mariani M; Pfizer Italia SRL, Milan, Italy.
  • Krishnaswami S; Pfizer, Groton, USA.
  • Cislo P; Pfizer, New York, USA.
  • Chudnovsky A; Pfizer, Cambridge, USA.
  • Fowst C; Pfizer Italia SRL, Milan, Italy.
  • Huang B; Pfizer, Groton, USA.
  • di Pietro A; Pfizer Italia SRL, Milan, Italy.
  • Albiges L; Institut Gustave Roussy, Villejuif, France.
Ann Oncol ; 31(8): 1030-1039, 2020 08.
Article en En | MEDLINE | ID: mdl-32339648
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido